Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

E. Coli Nissle 1917 - Suspension for Infection Prophylaxis

NCT02802059 is registered in ClinicalTrials.gov with Ardeypharm GmbH as lead sponsor.

NCT NCT02802059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02802059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
Lead sponsor
Ardeypharm GmbH
Phase
Phase 3
Overall status
Completed
Start date
October 7, 2015
Completion date
October 12, 2020
Enrollment
567 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

infections